Jussi Seppälä
Biographic Data
| ID | 6780662 |
|---|---|
| NAME | Jussi Seppälä |
| GIVEN NAMES | Jussi |
| FAMILY NAME | Seppälä |
| SIGNATURE | SEPPÄLÄ J |
| AFFILIATIONS | Oulu University Hospital |
| ORCID | 0000-0002-8752-2041 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia
Although the availability of services was different in each region, most of the services provided were sufficiently similar to allow the implementation of the same ICT solution in the three places
Results of the m-Resist feasibility study. A Mobile therapeutic attention for treatment-resistant schizophrenia
The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)
An innovative and integrative m-Health solution for treatment resistant schizophrenia patients
In the European Union, it is estimated that around 5 million people (0.2-2.6%) suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant (Juarez-Reyes et al., 1995; Essock et al., 1996). The standard intervention in patients with resistant schizophrenia is complex, mainly for the presence of persistent positive symptomatology, extensive periods of hospital care and greater risk of multi-m…
No prominent works on this page.
An innovative and integrative m-Health solution for treatment resistant schizophrenia patients
In the European Union, it is estimated that around 5 million people (0.2-2.6%) suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant (Juarez-Reyes et al., 1995; Essock et al., 1996). The standard intervention in patients with resistant schizophrenia is complex, mainly for the presence of persistent positive symptomatology, extensive periods of hospital care and greater risk of multi-m…
Results of the m-Resist feasibility study. A Mobile therapeutic attention for treatment-resistant schizophrenia
The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia
Although the availability of services was different in each region, most of the services provided were sufficiently similar to allow the implementation of the same ICT solution in the three places
Medicine (3 works) · Psychiatry (3 works) · Schizophrenia (object-oriented programming (3 works) · Digital Mental Health Interventions (2 works) · Mobile Health and mHealth Applications (2 works) · Computer Science (1 work) · Health care (1 work) · Intervention (counseling (1 work) · Mental Health and Psychiatry (1 work) · Mental Health Treatment and Access (1 work)